trihexyphenidyl has been researched along with Arteriosclerosis in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| HAFFNER, Z | 1 |
| POPPEL, A | 1 |
1 other study available for trihexyphenidyl and Arteriosclerosis
| Article | Year |
|---|---|
[Clinical experiences on comparative studies of the preparations. Parkan and Artane].
Topics: Arteriosclerosis; Humans; Parkinson Disease; Trihexyphenidyl | 1963 |